Theta Burst Stimulation (TBS) in Treatment Resistant Obsessive Compulsive Disorder.

Not Applicable

• Conditions: Obsessive Compulsive Disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12616000666426
• Lead Sponsor: Epworth HealthCare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-23
• Study Completion: 2019-02-11
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

Have DSM-5 diagnosis of OCD
- Are treatment resistant
- Have had no changes in medications in 6 weeks prior to screening

Exclusion Criteria

- An unstable medical condition, neurological disorder, history of seizure disorder or currently pregnant or lactating
-A current diagnosis of substance abuse or dependence, a personality disorder or other psychiatric disorder, except depression or another anxiety disorder
- Any contraindication to TMS

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Yale-Brown Obsessive-Compulsive Scale (YBOCS)[The YBOCS will be administered at baseline, at week 2 post start of treatment and at 4 - 6 weeks post treatment completion.]

Secondary Outcome Measures

Name	Time	Method
Beck Depression Inventory (BDI)[The BDI will be administered at baseline, at week 2 post start of treatment and at 4 - 6 weeks post treatment completion.];Beck Anxiety Inventory (BAI)[The BAI will be administered at baseline, at week 2 post start of treatment and at 4 - 6 weeks post treatment completion.];The Clinical Global Impression (CGI) scale.[The CGI will be administered at baseline, at week 2 post start of treatment and at 4 - 6 weeks post treatment completion.]